Researchers test TIMP-2 as potential tumor terminator.
Parkins
T
T
D000970:Antineoplastic Agents / Q000494:pharmacology*; D002356:Cartilage; D002455:Cell Division / Q000187:drug effects; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors*; D009363:Neoplasm Proteins / Q000494:pharmacology*; D019716:Tissue Inhibitor of Metalloproteinase-2
D000970:Antineoplastic Agents; D009363:Neoplasm Proteins; D019716:Tissue Inhibitor of Metalloproteinase-2; D008666:Metalloendopeptidases